California AB 2009 and Plasma Donor Protein Testing: Why Choosing the Right Digital Refractometer Matters

Plasma donation is an important part of the healthcare supply chain. Donated source plasma is used to manufacture essential plasma-derived therapies, including immunoglobulins, albumin, and clotting-factor products. Because plasma collection involves frequent donations from eligible individuals, reliable donor screening is an essential part of protecting donor health and maintaining appropriate collection procedures.

One of the important screening measurements is total plasma protein concentration, expressed in grams per deciliter (g/dL). Refractometry provides an established way to estimate total protein from a properly prepared serum or plasma sample.

For plasma collection centers, selecting the appropriate refractometer is not simply a question of finding a device that displays a protein reading. Instrument performance, sample preparation, operating procedures, quality control, staff training, and regulatory requirements all deserve careful attention.

California's Assembly Bill 2009 (AB 2009), enacted as Chapter 570 of the Statutes of 2026, addresses several aspects of plasma collection center operations, including personnel requirements for digital refractometer total protein testing. The legislation makes it particularly important for California facilities to understand how their testing equipment and procedures fit within the applicable requirements.

LegiScan

At NI Supply, we believe that understanding the measurement method is the first step toward selecting the right instrument. This guide explains plasma total protein refractometry, the relevant regulatory considerations, and the capabilities of the MISCO Palm Abbe PA203x-108-109-110-111 digital refractometer.

1. What Is Plasma Total Protein Testing?

Total protein testing measures the combined concentration of proteins in a blood-derived sample. Plasma contains proteins such as albumin, globulins, and other components that perform important biological functions.

In source plasma donation, total protein is one of the measurements used in donor eligibility procedures.

Under 21 CFR § 630.15(b)(4), the applicable U.S. source plasma donor requirement generally specifies a total protein concentration of no less than 6.0 g/dL and no more than 9.0 g/dL in a plasma or serum sample, subject to applicable regulatory provisions and exceptions.

GovInfo

+1

The purpose of screening is to help determine whether the donor meets the applicable protein requirement. The measurement is one part of the overall donor eligibility process, not a standalone determination of a person's complete medical condition.

A reliable screening process therefore depends on several factors:

• Appropriate specimen collection and preparation.

• A refractometer configured for the intended measurement.

• Suitable instrument performance.

• Proper standardization and quality-control procedures.

• Correct interpretation and documentation of results.

• Compliance with the facility's applicable operating procedures and regulatory requirements.

The instrument must be suitable for the intended testing workflow, and personnel must follow the procedures established by the collection facility.

2. Why Is Refractometry Used for Plasma Protein Measurement?

Refractometry measures the way light changes direction when it passes between materials with different refractive indices.

The refractive index of a liquid is influenced by its dissolved constituents. In a suitable serum or plasma sample, the relationship between refractive index and protein concentration can be used to produce an estimated total protein reading.

A digital refractometer applies its programmed measurement scale to the optical measurement and displays the result numerically.

MISCO identifies serum total protein measurement as an established application for refractometry, noting that the method has been used for decades as a rapid means of assessing serum total protein concentration.

MISCO Refractometer

A typical testing workflow

A conventional plasma protein refractometry workflow generally involves the following steps, performed according to the facility's approved procedure:

1. A blood sample is collected using an authorized procedure.

2. The sample is centrifuged to separate the plasma from the cellular components.

3. A suitable quantity of separated plasma is transferred to the refractometer's measurement surface.

4. The instrument produces a numerical reading on the configured total protein scale.

5. The result is recorded and evaluated according to the facility's donor eligibility procedure.

6. The measurement surface is cleaned, and required quality-control procedures are performed.

The process can be relatively quick, but speed must not come at the expense of specimen quality, quality control, or correct documentation.

Important: A digital refractometer's displayed resolution is not necessarily the same as its measurement accuracy. Facilities should evaluate manufacturer specifications and validated performance rather than relying on the number of decimal places displayed.

3. California AB 2009: What Plasma Collection Centers Need to Know

California AB 2009 concerns blood banks and plasma centers. It was approved and chaptered on September 27, 2026, as Chapter 570 of the Statutes of 2026.

LegiScan

The legislation amends California Business and Professions Code § 1246.7, which addresses the performance of total protein tests using digital refractometers in licensed plasma collection centers.

Requirements affecting digital refractometer testing

The enacted law addresses both the people performing the test and the equipment used.

Among the provisions in amended § 1246.7 are requirements concerning:

• Education and training of personnel performing total protein tests.

• Five hours of training in the proper procedures for digital refractometer total protein testing.

• Certification and documentation of that training.

• Appropriate supervision by specified qualified personnel, including onsite availability during specimen processing and testing.

• Standardized operating procedures approved by the appropriate supervising physician or clinical laboratory director.

• Competency evaluation before testing donors and every six months thereafter.

• Recording test results in an FDA 510(k)-approved blood establishment computer system.

• Quality-control procedures meeting applicable requirements.

• Use of a qualifying digital refractometer test system under the specified operating conditions.

  

  LegiScan

   

These provisions make it important for plasma collection centers to assess their entire testing process rather than focusing exclusively on the instrument purchase.

What does AB 2009 require of the digital refractometer?

The law specifies several equipment-related criteria. In particular, the digital refractometer used for the test must:

• Be used within 30 feet of the donor being tested.

• Operate within the applicable donor-test management and quality-assurance programs.

• Perform total protein tests classified as waived or moderate complexity under CLIA.

• Support the specified workflow involving blood collection, centrifugation, plasma separation, and application of plasma to the refractometer.

• Provide total protein results without calculations or discretionary intervention by testing personnel.

• Operate without the need for testing personnel to perform calibration or maintenance beyond the permitted basic cleaning, resetting, and daily standardization described in the statute.

  

  LegiScan

   

These details matter when comparing instruments for a regulated plasma collection environment.

Does purchasing the MISCO PA203x automatically make a facility AB 2009-compliant?

No. AB 2009 does not name MISCO or the PA203x as a mandated product, and buying a refractometer does not by itself satisfy the law's personnel, supervision, training, documentation, quality-control, and facility requirements.

The MISCO PA203x-108-109-110-111 has the appropriate type of displayed measurement for a facility evaluating total protein refractometry: its dedicated Scale 108 reports total protein in g/dL. However, the publicly available product specifications alone do not establish that the complete instrument/test system satisfies every applicable AB 2009 requirement, including its CLIA test-complexity criterion and operational requirements.

Before purchasing for California plasma donor eligibility testing, a collection center should obtain written confirmation from MISCO regarding the instrument's suitability for that specific use and the applicable regulatory requirements.

This distinction protects both the purchaser and the supplier: an instrument can have the correct measurement scale without necessarily satisfying every condition imposed on the complete testing system.

4. Introducing the MISCO Palm Abbe PA203x-108-109-110-111 Digital Refractometer

MISCO Palm Abbe PA203x-108-109-110-111

Four programmed human blood measurement scales

The PA203x is a handheld digital refractometer configured with four dedicated human blood scales. Its primary relevance to plasma protein screening is Scale 108, which displays total protein in g/dL.

The additional scales provide total solids, specific gravity, and density readings. This configuration allows users to access multiple measurement outputs on one instrument, although each output must be used only for an appropriate, validated application.

MISCO's published blood refractometer application page lists all four scale configurations and their measurement specifications.

MISCO Refractometer

Scale 108: Human Blood Total Protein

This is the most relevant scale for plasma total protein screening.

The 1–14 g/dL measurement range encompasses the 6.0–9.0 g/dL interval used in U.S. source plasma donor total protein requirements.

GovInfo

The instrument's stated resolution and precision are useful selection criteria. They should not, however, be interpreted as proof of independently verified accuracy under all sample and operating conditions. Facilities should obtain the manufacturer's performance documentation and verify that it meets their testing requirements.

Scale 109: Human Blood Total Solids

The total solids scale provides an additional refractometry measurement. Total solids and total protein are related concepts, but they are not interchangeable measurements. For donor protein eligibility decisions, the facility must use the designated total protein result and its approved procedure.

Scale 110: Human Blood Specific Gravity

Specific gravity provides a ratio-based measurement referenced to water under the stated temperature convention. It is a distinct output from the dedicated total protein scale.

Scale 111: Human Blood Density

The density scale reports a numerical density value in grams per milliliter. It provides another measurement output but should not be substituted for the total protein result when evaluating donor protein requirements.

5. Why a Digital Total Protein Scale Matters

Digital refractometers offer several practical advantages over traditional optical instruments in workflows where a numerical result must be read and documented.

Direct numerical display

A digital readout eliminates the need to interpret a visual boundary on a traditional analog scale. This can simplify result reading and recording.

Defined measurement units

The PA203x Scale 108 displays total protein in g/dL, the unit used in the relevant source plasma donor protein requirements.

Multiple measurement outputs

The four-scale configuration provides total protein, total solids, specific gravity, and density in one instrument. This may be useful to facilities that have a justified need for those additional outputs.

Compact handheld format

A handheld instrument can be convenient in a collection-facility workflow where testing takes place near the donor. For California facilities, the instrument's actual placement and operating arrangement must satisfy the applicable requirements, including the statutory 30-foot condition.

A defined manufacturer configuration

Ordering by the scale combination PA203x-108-109-110-111 helps identify the intended instrument configuration. Buyers should confirm the exact model and programmed scales on the quotation or purchase order so the delivered unit matches the required specification.

6. Accuracy, Standardization, and Quality Control

The quality of a plasma protein result depends on more than the instrument's display.

Total protein refractometry relies on the relationship between a sample's optical properties and its protein concentration. Other dissolved constituents and differences in sample handling can affect the relationship, so proper method validation is important.

For facilities evaluating the PA203x, questions worth discussing with the manufacturer include:

• What measurement accuracy and repeatability have been established for Scale 108?

• Under what conditions were the stated precision specifications determined?

• What standardization procedure is required before testing?

• What controls must be used, and at what frequency?

• What are the permitted cleaning, resetting, and maintenance procedures?

• Does the complete test system satisfy the applicable CLIA complexity and other requirements for the intended use?

• What written documentation supports use for plasma donor eligibility testing in California?

These questions are especially important when results influence donor eligibility decisions.

A device's ability to display readings to 0.1 g/dL does not by itself establish that its error is limited to ±0.1 g/dL. Resolution, precision, and accuracy describe different aspects of measurement performance and should be evaluated separately.

Facilities should use the manufacturer's instructions, validated procedures, appropriate controls, and their quality-assurance program to establish acceptable performance.

7. Other Applications for the MISCO Palm Abbe Platform

The Palm Abbe family supports numerous programmed refractometry scales, and MISCO offers customizable configurations. The PA203x described in this article, however, is specifically configured with four human blood scales.

MISCO Refractometer

Other applications may be worth exploring with a different scale configuration:

• Veterinary serum protein testing: Veterinary instruments may use species-appropriate total protein scales.

• Clinical laboratory measurement: Refractometry may support selected serum or plasma testing workflows when appropriate to the validated method.

• Hospital pharmacy monitoring: Refractometers can be used in certain controlled comparison workflows involving reference values, but the four human blood scales are not drug-identification tests.

• Research and quality control: Refractometry can be used for comparative measurements and method evaluation when supported by an appropriate protocol.

These examples refer to the broader refractometer platform and the general method, not a claim that the PA203x's four installed scales are validated for every application.

For plasma collection facilities, the most relevant consideration remains the dedicated Scale 108 total protein output and the suitability of the complete instrument/test system for the intended regulatory environment.

8. How to Evaluate a Refractometer Before Purchasing

A procurement decision should begin with the facility's intended use and operating requirements.

Step 1: Define the application. Confirm that the intended test is total protein measurement on an appropriate plasma or serum specimen.

Step 2: Confirm the programmed scale. Verify that the instrument includes Scale 108, with a 1–14 g/dL range and the required displayed units.

Step 3: Review the performance documentation. Request manufacturer specifications and evidence supporting accuracy and repeatability under the intended operating conditions.

Step 4: Verify regulatory suitability. Ask the manufacturer for documentation addressing the complete test system's applicable CLIA classification and the requirements relevant to California AB 2009.

Step 5: Review the operating workflow. Confirm sample preparation, permitted standardization and cleaning, control procedures, training, supervision, and documentation requirements.

Step 6: Document the purchasing decision. Keep the instrument specifications, manufacturer responses, approved procedures, and relevant quality records available to the facility's compliance and laboratory personnel.

This approach helps buyers choose an instrument based on verified performance and actual requirements rather than a marketing claim alone.

9. Why Consider NI Supply?

NI Supply specializes in refractometers and measurement instruments for laboratory, industrial, and specialized applications. Our catalog includes new and refurbished equipment, as well as hard-to-find refractometers for specific measurement needs.

We understand that selecting a refractometer involves more than comparing prices. The measurement scale, range, resolution, precision, intended sample, and required operating procedure all influence whether a particular instrument is appropriate.

For facilities evaluating the MISCO Palm Abbe PA203x-108-109-110-111, NI Supply can help identify the requested configuration and provide product information to support your purchasing evaluation.

Important for California plasma collection centers: Please obtain written confirmation from MISCO and your facility's compliance personnel before relying on this instrument for AB 2009 compliance. NI Supply does not represent that purchasing this product alone establishes regulatory compliance.

Frequently Asked Questions

What is California AB 2009?

California AB 2009, enacted as Chapter 570 of the Statutes of 2026, addresses blood banks and plasma centers, including personnel and operational requirements relating to digital refractometer total protein testing in licensed plasma collection centers.

LegiScan

What total protein range is required for source plasma donors?

Under 21 CFR § 630.15(b)(4), the applicable requirement generally specifies a total protein level between 6.0 and 9.0 g/dL, inclusive, subject to applicable provisions and exceptions.

GovInfo

What does the MISCO PA203x-108-109-110-111 measure?

It provides four human blood scales: total protein in g/dL, total solids in percent, specific gravity (D20/20), and density in g/mL. MISCO publishes the range, resolution, and precision for each scale on its blood refractometer application page.

MISCO Refractometer

Is the PA203x automatically AB 2009-compliant?

No such guarantee can be made from the published scale specifications alone. The law includes specific test-system criteria and requirements concerning staff qualifications, training, supervision, competency, quality control, and recordkeeping. The instrument's suitability must be confirmed for the intended application.

LegiScan

Is 0.1 g/dL resolution the same as ±0.1 g/dL accuracy?

No. Resolution describes the increment displayed by the instrument. Accuracy describes how closely a measurement agrees with the appropriate reference value, while precision describes measurement consistency. These characteristics must be evaluated separately.

Can the PA203x be used for veterinary testing or drug screening?

The PA203x's four installed scales are human blood scales. Veterinary protein testing or drug-related measurement workflows may require different programmed scales, different procedures, or other test methods. The current configuration should not be represented as a general drug-screening device.

Where can I find the manufacturer's specifications?

Visit the MISCO Blood Refractometer Application Guide for the published four-scale specifications.

Conclusion: Choosing the Right Refractometer for Plasma Protein Testing

Plasma total protein testing is an important part of source plasma donor eligibility procedures. Refractometry offers an established method for obtaining a rapid total protein measurement, but selecting an appropriate instrument requires attention to measurement performance, sample handling, quality control, and the applicable regulatory framework.

The MISCO Palm Abbe PA203x-108-109-110-111 is a purpose-configured digital refractometer with a dedicated total protein scale and three additional human blood measurement scales. Its direct g/dL readout and defined measurement range make it a compelling instrument to evaluate for plasma protein testing workflows.

California AB 2009 reinforces the importance of selecting suitable equipment and operating it within a documented, properly supervised, quality-controlled process. Before using this specific model for donor eligibility decisions, confirm the complete test system's suitability with MISCO and the facility's compliance personnel.

Looking for the MISCO Palm Abbe PA203x-108-109-110-111? NI Supply can help you identify the configuration and obtain the product information needed for your evaluation.

NI Supply — National Industrial Supply

Website: www.nisupply.com Email: sales@nisupply.com Office hours: Monday–Friday, 8:00 AM–4:30 PM Pacific Time, by appointment only.

NI Supply specializes in new and refurbished refractometers, laboratory instruments, and hard-to-find measurement equipment.